CellChorus

12:00 PM - 12:15 PM (PDT), Wednesday, June 15, 2022
CellChorus® conducts dynamic single-cell analysis to evaluate function and performance of individual cells and cell-cell interactions at scale.

The genesis of cells as living drugs requires that we evaluate how cells move, contact, kill, survive and secrete biomolecules as a function of time. Unfortunately, conventional bulk live-cell imaging provides average results for target cells and most single-cell technologies are destructive to cells.

CellChorus conducts Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) and applies artificial intelligence to "watch" and evaluate thousands of microscopy experiments in parallel.

Leading cell therapy companies and other scientists rely on CellChorus to advance the best candidates into IND-enabling studies, to evaluate response, and to deliver novel therapies.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Texas
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
CellChorus, LLC